| Income Statement |
| Total Revenue | 12.73M |
|
| Revenues (USD) | 12.73M |
| Cost of Revenue | 6.59M |
| Gross Profit | 6.15M |
| Operating Expenses | 9.65M |
| Research and Development Expense | 4.52M |
| Selling, General and Administrative Expense | 5.13M |
| Operating Income | -3.50M |
| Income Tax Expense | -2.09M |
| Net Income | 830.87K |
| Net Income Common Stock | 830.87K |
| Net Income Common Stock (USD) | 830.87K |
| Consolidated Income | 830.87K |
| Earning Before Interest & Taxes (EBIT) | -1.26M |
| Earning Before Interest & Taxes (USD) | -1.26M |
| Weighted Average Shares | 188.23M |
| Weighted Average Shares Diluted | 192.10M |
| Balance Sheet |
| Cash and Equivalents | 50.28M |
| Cash and Equivalents (USD) | 50.28M |
| Investments | 18.38M |
| Investments Non-Current | 18.38M |
| Trade and Non-Trade Receivables | 15.24M |
| Current Assets | 79.29M |
| Property, Plant & Equipment Net | 8.47M |
| Total Assets | 106.26M |
| Debt Current | 674.49K |
| Total Debt | 1.16M |
| Current Liabilities | 36.39M |
| Debt Non-Current | 488.11K |
| Total Liabilities | 37.05M |
| Accumulated Retained Earnings (Deficit) | -402.34M |
| Shareholders Equity | 69.21M |
| Shareholders Equity (USD) | 69.21M |
| Assets Non-Current | 26.97M |
| Total Debt (USD) | 1.16M |
| Deferred Revenue | 6.96M |
| Inventory | 4.73M |
| Liabilities Non-Current | 660.39K |
| Trade and Non-Trade Payables | 4.85M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 184.09K |
| Net Cash Flow from Financing | -1.07M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.21M |
| Capital Expenditure | -3.81M |
| Payment of Dividends & Other Cash Distributions | 29.17K |
| Net Cash Flow from Investing | -3.81M |
| Net Cash Flow from Operations | -4.33M |
| Effect of Exchange Rate Changes on Cash | 3.00 |
| Share Based Compensation | 973.52K |